Decline in reported GC morbidity in NYC Preeti Pathela

Where do we stand? NYC US Gonorrhea Cases per 100,000 pop.

Gonorrhea Rates: United States, and the Healthy People 2010 target -74% -12%

Gonorrhea Rates by Sex: United States, and the Healthy People 2010 target

Gonorrhea Rates by Sex New York City, Data based on cases reported to the NYC DOHMH

Gonorrhea Rates by Provider Type: United States,

Case rate (per 100,000 population) of Neisseria gonorrhea reported to the New York City DOHMH, with percent reported from Bureau of STD clinics, , by sex Data based on cases reported to the NYC DOHMH

HIV Counseling & Testing STD Clinic Drug Treatment Family Planning Prenatal Other Clinic Private Physician Hospital Correctional Facility Laboratory Other Unknown Provider types in NYC BSTDC Surveillance Database

N=5507N=5286 N=6720 N=6330

NYC DOHMH Reported female gonorrhea cases, by provider type N=5048N=5544 N=6691N=6646

Age (years) Males N=5286 Females N=5544 Gonorrhea reported to the NYC DOHMH. Case rates (per 100,000 population) by age and sex*, full year 2004 * Excludes persons for whom age or sex information is missing. Case rate /100,000 population

Male GC positivity by age BSTDC clinics,

Female GC positivity by age BSTDC clinics,

A true decline in GC Changes in screening practices Use of diagnostic tests with different sensitivities Changes in reporting practices What is leading to the apparent decline in GC cases?

If decreases are true decreases… How would this impact targeting of GC screening? Could this impact manufacturers of tests (provision of Ct-only tests) for low GC prevalence areas?

Thanks!